DOI: 10.1007/978-1-4020-8831-5_11
|View full text |Cite
|
Sign up to set email alerts
|

Phospholipid-Mediated Signaling and Heart Disease

Abstract: Cardiac hypertrophy, congestive heart failure, diabetic cardiomyopathy and myocardial ischemia-reperfusion injury are associated with a disturbance in cardiac sarcolemmal membrane phospholipid homeostasis. The contribution of the different phospholipases and their related signaling mechanisms to altered function of the diseased myocardium is not completely understood. Resolution of this issue is essential for both the understanding of the pathophysiology of heart disease and for determining if components of th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
12
0
1

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 21 publications
(14 citation statements)
references
References 158 publications
1
12
0
1
Order By: Relevance
“…Normal cardiac function depends on FA metabolism and, to a lesser degree, on glucose metabolism as an energy source (3,25,26). In contrast, the hypertrophied heart requires alternative energy sources and tends to rely more on glucose metabolism (25,(27)(28)(29).…”
Section: Discussionmentioning
confidence: 99%
“…Normal cardiac function depends on FA metabolism and, to a lesser degree, on glucose metabolism as an energy source (3,25,26). In contrast, the hypertrophied heart requires alternative energy sources and tends to rely more on glucose metabolism (25,(27)(28)(29).…”
Section: Discussionmentioning
confidence: 99%
“…Although we are proposing a metabolic component explaining improved function at baseline, it is also conceivable that cardiacspecific ATGL overexpression alters (lipid) signaling pathways to secondarily influence cardiac function. Given the connection between metabolism of phospholipids and TG (6,10,25,27) and emerging evidence showing that phospholipid metabolism and signaling influence cardiac function (27,41,43,44), it is also possible that altered TG metabolism in MHC-ATGL hearts modulates phospholipid homeostasis to enhance myocardial performance. Future research will help to test these possibilities.…”
Section: Discussionmentioning
confidence: 99%
“…Acute metabolic stress conditions such as ischemia and reperfusion may cause a change in phosphoinositide turnover (see [32]). In chronic diseases, reduced PIP 2 levels have been reported in hypertrophy, diabetic cardiomyopathy, and congestive heart failure [33]. Recent studies indicate that a loss of function of TRPM7 may underlie neurodegenerative diseases [13,18], and in the case of familial Alzheimer's diseases, 1 the underlying mechanism seems to involve an abnormal turnover of PIP 2 with decreased membrane PIP 2 levels and decreased TRPM7 current [18].…”
Section: Discussionmentioning
confidence: 99%